Crohn Disease
16 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.
Broader: Gastroenteritis, Inflammatory Bowel Diseases
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| ATG + CliniMACS® TCR α/β Reagent Kit and CliniMACS® CD19 System + Prednisone/Methylprenisolone + Total Body Irradiation + RITUXIMAB + CLOFARABINE + Melphalan + PALIFERMIN for crohn disease | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| AZD7798 for crohn disease | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Bezlotoxumab for crohn disease | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Brivekimig for crohn disease | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Fluconazole for crohn disease | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Guselkumab for crohn disease | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| H021 Enteric-coated Tablets High-dose Group for crohn disease | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| H021 Enteric-coated Tablets Low-dose Group for crohn disease | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Infliximab for crohn disease | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| infliximab (IFX) infusion; azathioprine (AZA) caps for crohn disease | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| infliximab (IFX) placebo infusion; azathioprine (AZA) caps for crohn disease | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Intermittent Reduced Calorie Diet (IRCD) for crohn disease | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| local co-administration of autologous ADIpose for crohn disease | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Placebo for crohn disease | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Risankizumab for crohn disease | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Vedolizumab for crohn disease | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.